- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Rpg Life Sciences covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
About Rpg Life Sciences
Rpg Life Sciences is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24232MH2007PLC169354). Business overview includes Pharma (API Manufacturers), incorporated on March 29, 2007 (19+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status. For FY 2023, the company reported revenue of ₹517.61 Cr with a profit of ₹67.64 Cr. It has 16 active directors. The company employs approximately 1,197 people. Its latest credit rating is A by Icra.
- Location Rpg House 463, Dr. Annie Besant Road, Worli, Mumbai, Maharashtra - 400030
- Website rpglifesciences.com
Financial Performance of Rpg Life Sciences
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,20,083.04 cr | 2,35,431.21 cr | 2,51,890.00 cr | 2,18,400.00 cr | 1,95,200.00 cr | 1,72,000.00 cr | 1,59,000.00 cr |
| Profit/Loss | 13,969.70 cr | 4,810.00 cr | 12,200.00 cr | 9,100.00 cr | -8,200.00 cr | 3,200.00 cr | 5,100.00 cr |
| Cash & Bank Balance | 38,200.00 cr | 35,100.00 cr | 32,000.00 cr | 28,500.00 cr | 25,200.00 cr | 22,000.00 cr | 19,800.00 cr |
| Net Worth | 1,26,731.94 cr | 1,37,500.00 cr | 1,40,200.00 cr | 1,28,000.00 cr | 1,15,000.00 cr | 1,02,000.00 cr | 95,000.00 cr |
| EBITDA | 27,865.49 cr | 29,800.00 cr | 30,200.00 cr | 27,000.00 cr | 24,500.00 cr | 22,000.00 cr | 20,100.00 cr |
Financial Ratios
Values in Crores (Cr) - illustrative trend
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Profit Margin | 10.54 | 3.20 | 2.10 | 1.80 | 0.50 |
| Debt to EBITDA | 2.14 | 1.90 | 1.70 | 1.50 | 1.20 |
| Interest Coverage Ratio | 0.47 | 0.50 | 0.45 | 0.40 | 0.35 |
| Debt to Equity | 0.88 | 0.90 | 0.85 | 0.80 | 0.75 |
| Return on Equity | 12.10 | 3.00 | 2.00 | 1.50 | 0.20 |
| Current Ratio | 1.20 | 1.15 | 1.10 | 1.05 | 0.99 |
| Quick Ratio | 0.95 | 0.92 | 0.88 | 0.85 | 0.80 |
| EBITDA Margin | 12.00 | 10.00 | 8.00 | 7.00 | 5.00 |
| Return on Capital Employed | 8.00 | 2.00 | 1.00 | 0.20 | 0.00 |
| Earning Per Share | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPFO Establishments (1)
Current Directors of Rpg Life Sciences (16)
Charges of Rpg Life Sciences
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 12 Apr 2017
|
20.00 cr | Closed |
|
Export Import Bank Of India
Creation Date: 25 Jan 2012
|
7.55 cr | Closed |
|
Export-Import Bank Of India
Creation Date: 28 Jan 2011
|
7.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Rpg Life Sciences
- Sachin Rajkumar Nandgaonkar
- Vasundhara Apoorva Patni
- Vishal Dilip Shah
- Rajesh Ramesh Shirambekar
- Hiten Kantilal Kotak
- Anilkumar Matai
- Rajat Bhargava
- Ashok Nair
- Manojkumar Madangopal Maheshwari
- Yugal Kishor Chothuram Sikri
- Radhika Gupta
- Harsh Vardhan Goenka
- Zahabiya Habil Khorakiwala
- Bhaskar Vemban Iyer
- Amol Narayan Lone
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.